Latest Revenue Forecast News

Page 1 of 18
IDT Australia expects FY27 revenue of $19 million to $20 million and EBITDA of $1 million to $1.5 million, marking a projected swing from a $0.92 million FY26 loss. The forecast rests on larger customer contracts, a five-year radiopharmaceutical deal and roughly $7 million of manufacturing upgrades.
Victor Sage
Victor Sage
18 Nov 2026
Xenitra has secured a three-year strategic cooperation agreement with JD Health carrying a non-binding A$100 million sales target across prescription medicines, OTC products, FSMP products and health products. The first order is expected in December, with sales targeted to begin in January 2027, but the agreement does not guarantee revenue or impose a penalty if the target is missed.
Victor Sage
Victor Sage
18 Nov 2026
Nike has laid out a five-year recovery plan targeting US$5 billion in incremental revenue by fiscal 2031, but the near-term picture remains difficult. Fiscal 2027 revenue is still expected to fall by a high-single-digit percentage, with restructuring costs weighing on earnings.
Logan Eniac
Logan Eniac
18 Nov 2026
First Graphene has signed a three-year agreement with China-based UNITEX to develop and commercialise graphene-enhanced carbon fibre prepreg and other advanced materials. The partnership offers manufacturing and customer access, but revenue, volumes and a commercial launch remain uncommitted.
Victor Sage
Victor Sage
16 Nov 2026
Cisco delivered its strongest revenue and non-GAAP earnings growth in more than 15 years, helped by a sharp acceleration in networking demand. The company lifted its fiscal 2027 outlook and now expects US$9 billion in AI infrastructure revenue from hyperscalers.
Sophie Babbage
Sophie Babbage
13 Nov 2026
Vinyl Group has confirmed its $38 million to $40 million FY27 revenue forecast after record quarterly revenue, with management targeting a sustainably EBITDA-positive monthly run-rate by December. The catch is that the forecast depends heavily on recently acquired businesses, while operating cash flow remains negative.
Victor Sage
Victor Sage
12 Nov 2026
Talga’s Talnode-C natural graphite anode has performed in a KRI battery cell that reached up to 8,000 cycles while retaining 75% capacity, roughly five times the life of a conventional cell. The result opens a potential customer-qualification path in Japan, but commercial supply remains uncommitted.
Victor Sage
Victor Sage
12 Nov 2026
FDC Consolidated Holdings has lifted its FY27 revenue guidance to $2.00-$2.08 billion and normalised EBIT guidance to $105-$110 million. The upgrade follows project execution, unaudited earnings performance and new contract wins, while its order book has grown 14% since June.
Victor Sage
Victor Sage
11 Nov 2026
Sunrise Energy Metals has completed its US$5 million strategic investment in Philadelphia-based Agni Semiconductor, linking its planned scandium production to an emerging memory-chip technology. The investment is aimed at manufacturability and foundry qualification, but the announcement gives no ownership percentage or commercialisation timetable.
Victor Sage
Victor Sage
10 Nov 2026
Monadelphous expects revenue of approximately $1.7 billion and net profit after tax of $80 million to $85 million for the six months to 31 December 2026. The guidance reflects elevated activity and $830 million of new contracts secured since 1 July, although the company expects work levels to moderate in the second half.
Victor Sage
Victor Sage
10 Nov 2026
Codan will acquire US mission-critical recording specialist Eventide Communications for about A$244 million, adding evidence capture and AI analytics to Zetron’s command-and-control software. The deal is expected to be mid-single-digit EPS accretive in its first full year, including synergies, but will also add debt and integration costs.
Sophie Babbage
Sophie Babbage
9 Nov 2026
US Medicare has set a national outpatient payment of US$31,265 for Epiminder’s Minder System implant procedure from 1 January 2027, up 13% on the 2026 rate. The decision gives hospitals a defined reimbursement benchmark ahead of Epiminder’s planned US commercial launch.
Ada Torres
Ada Torres
6 Nov 2026

Browse the archive

Full archive